Background: The analysis and interpretation of change in cognitive function test scores after
Introduction
The establishment of an association between the surgical procedure (CABG), and either shortor long-term cognitive change has been hampered by the use of studies involving only the CABG population, without comparison with suitable control groups. Short-term studies have compared the outcomes of CABG with those of other surgical procedures, such as orthopedic operations (1) , but these controls do not have the high incidence of underlying risk factors for vascular disease that occurs in the CABG population. The lack of appropriate controls is particularly problematic for interpretation of studies concerning long-term cognitive performance after CABG, where possible decline could be related to the surgical procedure, age-related change, underlying cerebrovascular disease (2) , or a combination of these factors.
We are involved in an ongoing study that allows comparison of patients receiving CABG with a group of individuals that have established coronary artery disease, but do not have surgery; these nonsurgical controls (NSC) have an incidence of risk factors for vascular disease similar to that of the CABG group. In the accompanying paper by Selnes et al. we compare the longitudinal performance of these two groups at baseline and 3, 12, and 36 months post surgery or enrollment.
A first question is whether the pattern of cognitive change in the CABG group differs from that observed in the NSC group. A second question is whether any differences are likely caused by the surgery.
Determining whether there are different short-term or long-term declines in cognitive function for CABG as compared to a control group is challenging for at least three reasons. First, cognitive function is a multidimensional construct, which is assayed by numerous cognitive tests designed to assess different aspects of cognition such as memory, language, or executive function. Second, measurements of cognitive function over time will be affected by several factors, including practice effects, age-related change, error of measurement, and any intervention effect. Finally, the demonstrated medical efficacy of CABG makes a randomized treatment trial comparing surgical and nonsurgical treatments difficult.
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In this paper, we discuss a hierarchical statistical model that can be used to quantify differences in change in cognitive function over time between the CABG and control groups. We use the statistical model to estimate the average cognitive function over time for the surgery and control groups, after adjusting for known differences in potential confounding variables, specifically age, gender, education, and the presence of symptoms of depression.
After a summary of the main ideas for hierarchical linear models, we estimate both short-term and long-term effects of CABG on cognitive function, while controlling for differences between the two populations at baseline and differences due to age, gender, education, and level of depressive symptoms. Finally, we combine the estimates of the surgery effects across many measures into domain-specific estimates of group differences. This method relies upon prior knowledge about the domains of cognitive function measured by each test.
The statistical approaches we have used for evaluation of prospective, longitudinal data comparing patients after CABG with a nonsurgical control group have general applicability to other clinical studies in which the goal is the evaluation of the impact of an intervention.
http://biostats.bepress.com/jhubiostat/paper45
Methods

Study Design
This is an observational study of 140 patients undergoing CABG and 92 nonsurgical cardiac 
Hierarchical Linear Statistical Model (4)
This section describes a now standard statistical model designed to capture the key components of the change in cognitive function over time for the individuals in our study and for their population, and to compare the typical change for persons who do and do not receive an intervention such as CABG. As an example we focus on a single cognitive domain, Verbal Memory; below we present a method for pooling results across tests to obtain the domain values.
The model is specified by the following assumptions:
-Each person has a unique level and time trend of cognitive function.
-Over periods of time, such as a few years, true cognitive function changes gradually and can be approximated by a smooth function of time, such as a low order polynomial (5).
-The intervention may affect people in the short term by immediately increasing or decreasing their function; and over the longer term by changing their pre-intervention trend. The short-term and long-term effects of intervention may vary across individuals.
-The level of cognitive function is influenced, possibly in a nonlinear way, by other factors such as age, gender, education, and level of depressive symptoms.
-Measurements of cognitive function are subject to a practice effect whereby a study participant's scores on quantitative tests could improve with repetition, particularly from the first to second testing, absent a change in actual cognitive function level.
Below is presented a schematic of this model. The goal is to estimate the effects of an intervention from a dataset comprising repeated observations on cognitive tests over time for persons who have received the intervention and other similar persons who have not. The proposed model has two degrees of freedom to quantify a possible effect of CABG: the rise from 0 to 3 months (short-term, or learning effect); and a difference in the slope from 3 to 36 months (long-term effect). We use a Wald test (6) of the null hypothesis of no CABG effect by testing whether both are equal to 0.0.
The model has the ability to reduce bias caused by differential missing data between the groups when dropout is related to past cognitive score, resulting in individuals seen at all follow-up points having a different distribution of scores to the entire group. The model uses information from previous time-points and group patterns to internally impute missing data at later follow-up points
and make more precise estimates of the true group means.
Estimating Natural Heterogeneity
In addition to estimating the mean curves for each intervention group, the model is used to estimate the variance among the true levels and trends in a cognitive test score among persons within groups (5). We allow this degree of variation to differ between the two intervention groups.
Evidence for this natural variation derives from the correlation among repeated observations on each individual.
Pooling Intervention Effects Across Cognitive Measures
The hierarchical model in Appendix 2 is estimated separately for each of the 16 measures of cognitive function. This produces, for each measure, a short-and long-term intervention effect estimate and a 2x2 covariance matrix that quantifies their statistical error. We estimate the mean
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short-or long-term "effect" for a domain as the mean of the effects for the tests in that domain.
Since the multiple test scores for an individual are correlated with one another, estimates of the CABG effects for the different measures are also correlated. To correctly estimate the standard errors of these domain-specific or overall effects, we must take this correlation into account. We use bootstrapping (7), re-sampling individuals, to estimate the joint covariance matrix among the 16 pairs of intervention effect estimates and to obtain valid standard errors for the domain and overall intervention effect estimates. We draw with replacement a random sample of 140 CABG and 92
NSC subjects, refit all 16 models to get test-specific short-and long-term effect estimates, average these to obtain domain and overall effect estimates, and then repeat this process 1000 times. The variance among the 1000 bootstrapped replicates of the domain and overall effect estimates gives a valid estimate of statistical uncertainty, used to calculate the confidence intervals of the effect estimates, as it takes appropriate account of the correlation among multiple cognitive test scores for the same individual.
Results
The analyses were performed using the R software package (8) . that in this dataset, there is little or no evidence consistent with a detrimental effect of CABG on cognitive function as measured by these 8 scores.
Discussion
We have used a hierarchical linear statistical model to quantify the evidence relevant to assessing whether CABG causes short-or long-term decline in cognitive functioning. Our approach was to estimate this model separately for each of the cognitive measures and to pool the results across measures into cognitive domain effects. We take appropriate account of the correlation among repeated measures for an individual when setting confidence intervals for the average domain effects.
The findings in this study emphasize the importance of having a control group for at least two reasons. First, there is strong evidence in both groups of an improvement in the mean score from baseline to 3 months indicative of a learning effect. In 15 out of the 16 cognitive test measures, the mean score increased over this initial period in the CABG group. If only the CABG data were available, what appears to be a learning effect might be mistaken as a benefit of the intervention.
Second, there is a mix of positive and negative trends over the 36 months in the CABG group for the different cognitive tests and domains. But these trends were statistically different from the trends observed in the NSC group for only two domain measures and in both cases showed a positive effect of CABG at 36 months. Hence a trend in the CABG group data should not be mistaken for evidence of a treatment effect without comparison with controls.
The model described here estimates the average difference between the CABG and control groups in the change in cognitive function from baseline. We use the model to adjust for baseline differences between the groups in test scores and for differences over time that are attributable to demographics and depression symptoms, the latter as measured by the CESD.
However, no model can adjust for unmeasured differences between the two groups that are more likely to arise in observational studies where subjects choose their treatment in consultation with their physician rather than having it assigned by a known, random mechanism. Hence, we http://biostats.bepress.com/jhubiostat/paper45 must be cautious in our interpretation of the evidence, asking what other factors might account for the differences or lack thereof between the two groups.
The hierarchical model allows one to take appropriate account of dropouts, a common phenomenon in longitudinal studies such as this one. The model includes terms that acknowledge the correlation among repeated observations for each individual. Having done so, it can internally impute missing values by predictions based upon the earlier responses and other covariates (5).
Failure to use a model that accounts for within-person correlation can lead to biased estimates of treatment effects except when the dropout process is independent of the past responses, which is unlikely.
We have presented an approach to the difficult problem of how to estimate the effect of CABG on the performance of 16 cognitive measures by first analyzing each of them separately with an hierarchical model and then pooling the effect estimates to obtain domain effects. We refer to this as the "analyze then summarize" approach. An alternative is to "summarize then analyze" the data by using factor analysis (10) or some other method to create summary scores from the 16 test results and then to use hierarchical models with the summary measures. We prefer our approach because it produces a separate treatment effect for every measure so that unanticipated patterns can be discovered. It avoids the difficult problem of how to choose the best summary scores.
Typically, summarization is based upon the correlation among test results at one time and does not take appropriate account of the longitudinal information.
The methods used here have wide application to a variety of longitudinal studies comparing intervention groups or groups defined in other ways when the outcome is multivariate. To facilitate the application of these methods, software to implement the analyses presented here has been posted to our webpage (http://www.biostat.jhsph.edu/research/software.shtml). 
We then assume that the baseline curve can be approximated by a linear function with intercept and trend that are specific to each person (i):
We let the level at baseline 
We assume that collectively, the intercepts and trends for the cognitive function of time absent intervention (b 0i ,b 1i ) and for the intervention effect (δ 0i ,δ 1i ) can be thought of as samples from a
Gaussian distribution with variances G b and G d .
Finally, we acknowledge that the measured cognitive test score includes a learning effect assumed to be roughly constant after the baseline measure plus statistical noise that is assumed to be independent from one time to the next, that is:
The model represented by equations (1) - (5) can be readily simplified to deal with the case of a single group. This reduced model is defined by equations (2), (3) and (5) 
